Overview

Dexmedetomidine-propofol-remifentanil Anaesthesia and Reactivity to Noxious Stimuli

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Dexmedetomidine acts at central nervous system (specifically: at locus caeruleus), providing sedative and analgesic effects. It is widely used in intensive care. Surgery-related interventions elicit arousal ('nociceptive') reactions. The effects of dexmedetomidine on the neurophysiological signs of arousal are studied in surgical patients. Brain waves, electrocardiogram, Entropy Index, Bispectral Index, and fingertip pulse waves are recorded and analyzed later on. The course of anaesthesia and surgery are recorded.
Phase:
Phase 4
Details
Lead Sponsor:
Arvi Yli-Hankala
Treatments:
Anesthetics
Dexmedetomidine
Propofol
Remifentanil